The arrival of Retatrutide ZPHC, at a strength of 120mg, is creating considerable interest within the weight loss community. This novel dual GIP and GLP-1 agonist medication seems to provide impressive improvements in fat loss compared to previous therapies. Early clinical data have indicated sub